BACKGROUND: High rates of psychiatric co-morbidity have been reported in patients with irritable bowel syndrome (IBS) and high rates of post-traumatic stress disorder (PTSD) have been reported in fibromyalgia, a disorder also associated with IBS. The primary aim of this study was to assess the frequency of PTSD in IBS patients. METHODS: Sixty-four patients who fulfilled the Rome II diagnostic criteria for IBS were asked to complete questionnaires measuring the prevalence and severity of symptoms of PTSD and psychological distress. RESULTS: Although 86% of IBS patients reported a traumatic life experience, only 7.8% met the diagnostic criteria for PTSD. High rates of somatization, obsessive-compulsive behavior, interpersonal sensitivity, and anxiety symptoms were seen among the IBS patients. CONCLUSIONS: The results show a lower than expected prevalence of PTSD among IBS patients, which is similar to that of the general population. Thus, we did not find that PTSD is over-represented in a sample population of IBS patients.
BACKGROUND: High rates of psychiatric co-morbidity have been reported in patients with irritable bowel syndrome (IBS) and high rates of post-traumatic stress disorder (PTSD) have been reported in fibromyalgia, a disorder also associated with IBS. The primary aim of this study was to assess the frequency of PTSD in IBSpatients. METHODS: Sixty-four patients who fulfilled the Rome II diagnostic criteria for IBS were asked to complete questionnaires measuring the prevalence and severity of symptoms of PTSD and psychological distress. RESULTS: Although 86% of IBSpatients reported a traumatic life experience, only 7.8% met the diagnostic criteria for PTSD. High rates of somatization, obsessive-compulsive behavior, interpersonal sensitivity, and anxiety symptoms were seen among the IBSpatients. CONCLUSIONS: The results show a lower than expected prevalence of PTSD among IBSpatients, which is similar to that of the general population. Thus, we did not find that PTSD is over-represented in a sample population of IBSpatients.
Authors: Jennifer S Labus; Catherine S Hubbard; Joshua Bueller; Bahar Ebrat; Kirsten Tillisch; Michelle Chen; Jean Stains; George E Dukes; Dennis L Kelleher; Bruce D Naliboff; Michael Fanselow; Emeran A Mayer Journal: Gastroenterology Date: 2013-08-14 Impact factor: 22.682
Authors: Jaimie L Gradus; Dóra Körmendiné Farkas; Elisabeth Svensson; Vera Ehrenstein; Timothy L Lash; Henrik Toft Sørensen Journal: Epidemiology Date: 2017-05 Impact factor: 4.822
Authors: Tiffany H Taft; Alyse Bedell; Meredith R Craven; Livia Guadagnoli; Sarah Quinton; Stephen B Hanauer Journal: Inflamm Bowel Dis Date: 2019-08-20 Impact factor: 5.325
Authors: Arpana Gupta; Lisa Kilpatrick; Jennifer Labus; Kirsten Tillisch; Adam Braun; Jui-Yang Hong; Cody Ashe-McNalley; Bruce Naliboff; Emeran A Mayer Journal: Psychosom Med Date: 2014 Jul-Aug Impact factor: 4.312
Authors: Kevin C Cain; Monica E Jarrett; Robert L Burr; Sheldon Rosen; Vicky L Hertig; Margaret M Heitkemper Journal: Dig Dis Sci Date: 2008-11-01 Impact factor: 3.199
Authors: Heidi Glynn; Stephan P Möller; Helen Wilding; Pragalathan Apputhurai; Gregory Moore; Simon R Knowles Journal: Dig Dis Sci Date: 2021-01-12 Impact factor: 3.199